Renal biomarkers for assessment of kidney function in renal transplant recipients: how do they compare?

详细信息    查看全文

• 作者：Samra Abouchacra (1)
  Ahmed Chaaban (1)
  Raafat Hakim (1)
  Nicole Gebran (3)
  Hanan El-Jack (1)
  Faiz Rashid (1)
  Yousef Boobes (1)
  Amna Muhairi (4)
  Qutaiba Hussain (1)
  Imran Khan (1)
  Fares Chedid (5)
  Nico Negelkerke (2)
  
• 关键词：Renal biomarkers ; GFR estimation ; Renal transplantation
• 刊名：International Urology and Nephrology
• 出版年：2012
• 出版时间：December 2012
• 年：2012
• 卷：44
• 期：6
• 页码：1871-1876
• 全文大小：232KB
• 参考文献：1. Poge U, Gehardt T, Palmedo H et al (2005) MDRD equations for estimation of GFR in renal transplant recipients. Am J Transpl 5:2306 CrossRef
  2. Matsushita K, Selvin E et al (2010) Risk implication of the new CKD Epi equation compared with MDRD study equation for eGFR The (aric study). AJKD 55(4):648鈥?59 CrossRef
  3. White CA, Akbari A, Doucette S, Fergusson D, Knoll GA (2010) Estimating glomerular filtration rate in kidney transplantation: is the new chronic kidney disease epidemiology collaboration equation any better? Clin Chem 56(3):474鈥?77 Epub 2009 Dec 3 CrossRef
  4. P枚ge U, Gerhardt T, Stoffel-Wagner B, Palmedo H, Klehr HU, Sauerbruch T, Woitas RP (2008) Can modifications of the MDRD formula improve the estimation of glomerular filtration rate in renal allograft recipients? NDTT 23(7):2427鈥?428 CrossRef
  5. P枚ge U, Gerhardt T, Stoffel-Wagner B, Sauerbruch T (2011) Woitas RP Validation of the CKD-EPI formula in patients after renal transplantation. NDT 26(12):4104鈥?108 CrossRef
  6. Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S. (2008)Serum NGAL as a markers of renal function in non-diabetic patients with stage 2-4 CKD. Ren Fail 2008. 30(6):625-628.
  7. Malyszko J, Bachorzewska-Gajewska H (2009) NGAL is a new and sensitive marker of kidney function in CKD patients and renal allograft recipients. Transpl Proc 41:158鈥?61 CrossRef
  8. Stefan S, Michael M, Gideon H (2007) Detection of subclinical tubular injury after renal transplantation, comparison of urine protein analysis with allograft histology. Transplantation 84(1):104鈥?12 CrossRef
  9. Bargnoux AS, Perrin M (2011) Analytical performance of Cystatin C turbidimetric assay which impact on accuracy of glomerular filtration rate estimation in renal transplantation. Clin Chem Lab Med
  10. Delanage P, Pieroni L, Abshoff C, Lutteri L, Chapelle JP, Krzesinski JM, Hainque B, Cavalier E. (2008) Analytical study of three cystatin C assay and their impact on cystatin c-based GFR prediction equations. Clin Chem Acta 398(1鈥?):118鈥?24
  11. Hogs B, Ekart R (2006) Serum Cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transpl 21:1855鈥?862 CrossRef
  12. Mishra J, Pada A, Ma Q (2003) Identification of NGAL as novel early urinary biomarker for ischemic renal injury. J Am Soc Nephro 14:2534 CrossRef
  13. Mishra J, Pada A, Ma Q (2006) Kidney NGAL is a novel early marker of acute renal injury following transplantation. Pediatric Nephrol 21:856 CrossRef
  14. Nickolas TL, O鈥橰ourke MJ, Yang J (2008) Sensitivity and specificity of a single emergency department measurement of urinary NGAL for diagnosis of AKI. Ann Intern Med 148:810
  15. Bolignano D, Lacquanitii A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M (2009) NGAL and progression of chronic kidney disease. CJASN 4(2):337鈥?44
  16. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for CKD: evaluation, classification, and stratification. Am J Kidney Dis 39:S1鈥揝266 CrossRef
  17. Mitsnefes MM, Kathman TS, Mishra J et al (2007) Serum neurtrophil gelatinase- associated lipocalin as a marker of renal function in children in with chronic kidney disease. Pediatr Neprhol 22:101鈥?08 CrossRef
  18. Chandhary K (2010) The emerging role of bio-markers in diabetes and hypertensive CKD. Curr Diab Resp 10:32鈥?2 CrossRef
  
• 作者单位：Samra Abouchacra (1)
  Ahmed Chaaban (1)
  Raafat Hakim (1)
  Nicole Gebran (3)
  Hanan El-Jack (1)
  Faiz Rashid (1)
  Yousef Boobes (1)
  Amna Muhairi (4)
  Qutaiba Hussain (1)
  Imran Khan (1)
  Fares Chedid (5)
  Nico Negelkerke (2)
  
  1. Department of Nephrology, Tawam Hospital, P.O. Box 152 58, Al Ain, UAE
  3. Pharmacy Department, Tawam Hospital, P.O. Box 152 58, Al Ain, UAE
  4. Department of Internal Medicine, Tawam Hospital, P.O. Box 152 58, Al Ain, UAE
  5. Department of Pediatrics, Tawam Hospital, P.O. Box 152 58, Al Ain, UAE
  2. Faculty of Medicine and Health Sciences, UAEU, Al Ain, UAE
  
• ISSN：1573-2584

文摘

Accurate assessment of renal function is of key importance, given its prognostic value. However, gold standard measures are cumbersome, and serum creatinine itself is an insensitive predictor, especially in renal transplant recipients. Though GFR-estimating formulae have been relied upon, they do have their own limitations. Nevertheless, renal biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C, among others, are now emerging as potentially useful indicators of GFR. We aimed to evaluate the diagnostic performance of NGAL versus cystatin C and eGFR using CKD-EPI, MDRD and cystatin C in renal transplant recipients and non-transplant CKD patients. We found a significant correlation between NGAL, serum creatinine, cystatin C and eGFR. The latter parameters were also strong predictors of serum NGAL levels. However, performance of NGAL, based on receiver operating characteristic curves, was inferior to that of the reference tests. It appears that in renal transplant recipients NGAL correlates well with cystatin C and eGFR, most strongly with cystatin-based formula. Though this suggests potential use of NGAL as a screening test, its weaker diagnostic performance raises some concern about its clinical usefulness. Larger studies are needed to explore this further.